ANDA 62049, held by Pfizer. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 62049 (Pfizerpen-A), held by Pfizer, was first approved by FDA on Dec 2, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 2, 1977 | Original application | Approved | None posted |
| Pfizerpen-AEQ 125MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Pfizerpen-AEQ 250MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters